All antibodies articles
-
NewsPotential of antibody therapy in treating tick-borne diseases
A new study identifies multiple targets for antibodies that could open new paths toward treatments for Crimean-Congo hemorrhagic fever.
-
NewsWhy immune responses to vaccines vary from person to person
A new study finds that past immune encounters may predict future vaccine response.
-
NewsLab identifies gap in malaria vaccines, added peptides can strengthen response
The two vaccines in use today rally the immune system against a single region of the malaria parasite. A new study finds that adding short peptides for two overlooked regions broadens the response and strengthens protection.
-
NewsHow bats tolerate viruses: study sheds light on one of nature’s biggest immune mysteries
Researchers have found that the world’s largest family of bats has two distinct copies of the genes that produce antibodies, the specialized proteins that help the immune system recognize and fight infections. Every other known mammal has only one such set.
-
NewsAntibody clues could improve long Covid care and prognosis
Researchers have found that SARS-CoV-2 antibody patterns may help assess infection history, symptom severity, and cognitive complications in long Covid.
-
NewsScientists take crucial step in developing world’s first measles treatment
Scientists have characterized human antibodies capable of neutralizing measles virus. These antibodies bind to key sites on measles virus and prevent the virus from entering host cells.
-
NewsResearchers uncover how obesity impairs vaccine response
New findings reveal that obesity significantly impaired the quality and longevity of antibody responses to a Pseudomonas aeruginosa vaccine in a mouse model. The impaired antibody production was due to defects in germinal centers.
-
NewsMothers' exposure to microbes protect their newborn babies against infection
A study dives into new depths to explore why only some babies develop severe infection to common bacteria. The research revealed that the babies that became most severely ill from E. coli infections also had markedly lower levels of germ-fighting antibodies transferred from their mothers.
-
NewsHIV antibody opens up new approaches for vaccine development and combination therapies
An international research team has identified a novel HIV antibody that targets the virus at a particularly vulnerable site and overcomes previous limitations of known antibodies. The study opens up new perspectives for the development of vaccines and therapeutics against HIV-1.
-
NewsSome antibodies outmaneuver germs from sticking to cells
Researchers have uncovered several new mechanisms by which antibodies block E. coli bacteria that cause urinary tract infections from attaching to bladder cells. Once E. coli bacteria get a strong grip, they can be difficult to flush out.
-
NewsNo-needle test can tell if flu/COVID vaccines are effective
A team of researchers has developed a skin patch that can detect antibodies associated with COVID and flu infections. It’s orders of magnitude more sensitive than existing tests, uses just a half volt of electricity, and can return results in 10 minutes.
-
NewsMeasles immunity 90% in BC’s Lower Mainland
In British Columbia’s Lower Mainland, 90% of people have detectable antibodies against measles, indicating high vaccine coverage and population protection, according to a new study.
-
NewsAntibody discovered that blocks almost all known HIV variants in neutralization assays
An international research team has discovered an antibody that could advance the fight against HIV. The newly identified antibody 04_A06 proved to be particularly effective in laboratory tests. It was able to neutralize 98.5 percent of more than 300 different HIV strains, making it one of the broadest antibodies against HIV identified.
-
NewsResearch identifies immune response that controls Oropouche infection and prevents neurological damage
Research conducted on mice has identified that the rapid response of a specific type of defense cell is essential for controlling Oropouche virus infections and preventing serious neurological damage.
-
News‘One and done’: A single shot at birth may shield children from HIV for years, study finds
A new study shows that delivering a single injection of gene therapy at birth may offer years-long protection against HIV, tapping into a critical window in early life that could reshape the fight against pediatric infections in high-risk regions.
-
NewsNew strategy developed to engineer high-affinity receptor-containing antibodies against malaria
Researchers have introduced an innovative approach to developing high-affinity receptor-containing antibodies in vitro, offering a promising strategy to combat malaria.
-
NewsGenes combined with immune response to Epstein-Barr virus increase MS risk
In multiple sclerosis (MS), antibodies to the common Epstein-Barr virus can accidentally attack a protein in the brain and spinal cord. New research shows that the combination of certain viral antibodies and genetic risk factors can be linked to a greatly increased risk of MS.
-
NewsPurified immunoglobulin F(ab′) 2 prevents lethal staphylococcal enterotoxin B intoxication in mice and rhesus monkeys
Purified F(ab′)2 fragments are an effective antidote to lethal SEB doses in mice and rhesus monkeys, and therefore might be a favorable candidate for treating patients with severe SEB intoxication, a new study suggests.
-
NewsResearch identifies key antibodies for development of broadly protective norovirus vaccine
A new study identifies powerful antibodies capable of neutralizing a wide range of norovirus strains. The finding could lead to the design of broadly effective norovirus vaccine, as well as the development of new therapeutic antibodies.
-
NewsScientist who deployed glowing stars to detect disease named fellow of the Royal Society of Chemistry
The man who turned the science of glow-in-the-dark stars into ways to detect disease, Professor Richard Willson, has been elected as a fellow of the Royal Society of Chemistry.